The determination of drugs, metabolites and biomarkers in biological samples 13 continues to present one of the most difficult challenges to analytical scientists. 14 Matrices such as plasma, serum, blood, urine or tissues for example, usually 15 contain the analyte(s) of interest at low concentration in the presence of many 16 other components which may interfere directly or indirectly with the accurate 17 determination of species and concentration. Historically, the most common 18 methods have involved some form of extraction or isolation such as liquid-liquid 19 extraction (LLE), solid phase extraction (SPE) or protein precipitation. For a 20 recent review of sample preparation methods for bioanalysis, see [1] . This 21 includes comments on costs, automation, and miniaturisation with an overall 22 focus on productivity. 23
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24
Accurate quantitative measurement over the last 40 years has traditionally been 25 carried out by chromatography, mainly high performance liquid chromatography 26 (HPLC) and occasionally gas chromatography (GC). Although a range of 27 detectors has been available for both, most typically, HPLC used ultraviolet (UV) 28 and GC used flame ionisation and then both have used mass spectrometry (MS). 29
Sample preparation has been usually by a variant of LLE, SPE or protein 30 precipitation [2] . As the need for greater sensitivity has been a constant 31 challenge, sophisticated and more selective methods of sample preparation have 32 been explored. One of the most attractive of these has been the use of 33 commonplace. In many applications the MIPs will often only work satisfactorily 104 when the rebinding is carried out in the solvent in which the MIP was 105 synthesised, typically organic solvents. This is a considerable drawback when the 106 need is to extract from aqueous biological fluids such as plasma, serum, urine, 107 tissue extracts and faeces. It is also unsuitable for most macromolecules of 108 biological interest as they are not stable in organic solvents. Biologicals (greater 109 than 1000 Da) are metastable and can undergo intra-molecularly-induced 110 changes in conformation depending on their chemical environment. They 111 therefore need to be exposed to less harsh polymerisation conditions compared 112 with the imprinting of small and robust molecules (less than 700 Da) the latter 113 inherently possessing less degrees of freedom in molecular arrangement. MIP 114 preparations for biologicals have therefore focused on the use of water-115 compatible polymers, namely hydrogels based on using acrylamide (AAm) as a 116 functional monomer [25] [26] [27] and the repertoire extended more recently using a 117 combination of acrylo-based functional monomers to polymerise in the presence 118 of a second (more biocompatible) polymer including polyethylene glycol (PEG) 119 and chitosan [28] . Chitosan is a derivative of chitin (extracted from crustacean 120 species), and is produced by deacetylation of chitin under alkaline conditions. At 121 around physiological pH and below, chitosan is positively charged. and release of the target using temperature, rather than the much more 176 widespread use of a change of solvent or pH. 177
178
The basic principle of using a selective extraction followed by desorption into a 179 chromatograph with an MS detector or other instrumental technique is attractive, 180
as accurate measurement and a high degree of specificity or identification can be 181 was overcome by using a genetically modified virus-like particle as the template. 315
The paper showed a much larger binding to the MIP compared with the NIP. 316
Field emission scanning electron microscopy pictures were also shown as 317 evidence of MIP structure. 
Executive Summary 418
Background 419  The measurement of drugs, metabolites and endogenous compounds is a 420 very challenging area for Analytical Chemists. The most common methods 421 involve some form of extraction to give sample clean up and pre-422 concentration. This is then followed by injection into a gas or liquid 423 chromatograph and measurement using a variety of detectors but most 424 commonly nowadays mass spectrometry. 
